Abstract
Purpose Current sit-to-stand methods measuring dynamic cerebral autoregulation (dCA) do not capture the precise onset of the time delay (TD) response. Reduced sit-to-stand reactions in older adults and individuals post-stroke could inadvertently introduce variability, error, and imprecise timing. We applied a force sensor during a sit-to-stand task to more accurately determine how TD before dCA onset may be altered.
Methods Middle cerebral artery blood velocity (MCAv) and mean arterial pressure (MAP) were measured during two sit-to-stands separated by 15 minutes. Recordings started with participants sitting on a force-sensitive resistor for 60 seconds, then asked to stand for two minutes. Upon standing, the force sensor voltage immediately dropped and marked the exact moment of arise- and-off (AO). Time from AO until an increase in cerebrovascular conductance (CVC = MCAv/MAP) was calculated as TD.
Results We tested the sensor in 4 healthy young adults, 2 older adults, and 2 individuals post-stroke. Healthy young adults stood quickly and the force sensor detected a small change in TD compared to classically estimated AO, from verbal command to stand. When compared to the estimated AO, older adults had a delayed measured AO and TD decreased up to ~53% while individuals post-stroke had an early AO and TD increased up to ~14%.
Conclusion The transition reaction speed during the sit to stand has the potential to influence dCA metrics. As observed in the older adults and participants with stroke, this response may drastically vary and influence TD.
New & Noteworthy We developed a force sensor and are the first to apply it during sit-to-stands measuring the dynamic cerebral autoregulation (dCA) response. Current methodologies estimate the transition reaction speed of the sit-to-stand, which influences the dCA metrics. Compared to estimating the kinetic moment of arise-and-off (AO), our force sensor can detect early or delayed AO in individuals who may present with lower extremity weakness such as older adults and clinical populations such as stroke.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
AW was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (T32HD057850). SA was supported by a CTSA grant from NCATS awarded to the University of Kansas for Frontiers: University of Kansas Clinical and Translational Science Institute (TL1TR002368). SB and EV were supported in part by the National Institute on Aging for the KU Alzheimers Disease Research Center (P30AG072973). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. REDCap at University of Kansas Medical Center is supported by Clinical and Translational Science Awards (CTSA) Award # ULTR000001 from National Center for Research Resources (NCRR). The Georgia Holland Research in Exercise and Cardiovascular Health (REACH) laboratory space was supported by the Georgia Holland Endowment Fund.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the University of Kansas Medical Center Institutional Review Board Human Subjects Committee
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
